Internal Reference Number: FOI_6916
Date Request Received: 14/12/2022 00:00:00
Date Request Replied To: 16/12/2022 00:00:00
This response was sent via: By Email
Request Summary: Medication Query
Request Category: Companies
Question Number 1: How many patients have been treated (for any condition) in the last 4 months with: • Benralizumab • Dupilumab • Omalizumab • Reslizumab • Mepolizumab • Tezepelumab | |
Answer To Question 1: Benralizumab 0 • Dupilumab 19 • Omalizumab 18 • Reslizumab 0 • Mepolizumab 0 • Tezepelumab 0 | |
Question Number 2: Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups: • Age 6-11 • Age 12-17 • Age 18 and above | |
Answer To Question 2: Age 6-11 0 • Age 12-17 0 • Age 18 and above 37 | |
Question Number 3: How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with : • Dupilumab • Omalizumab | |
Answer To Question 3: • Dupilumab 0 • Omalizumab 12 | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.